Sunshine Biopharma (SBFM) News Today $1.56 -0.02 (-0.95%) As of 12:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Sunshine Biopharma (NASDAQ:SBFM) Cut to Sell at Wall Street ZenJuly 21 at 2:17 AM | americanbankingnews.comSunshine Biopharma Launches NIOPEG (R) Into $10 Billion Biologics Market - MorningstarJuly 3, 2025 | morningstar.comMSBFM - Sunshine Biopharma Inc News - MorningstarJuly 3, 2025 | morningstar.comMSunshine Biopharma, Inc. (SBFM) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comSunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’June 11, 2025 | msn.comSunshine Biopharma Inc.: Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion MarketMay 6, 2025 | finanznachrichten.deSunshine Biopharma launches Everolimus in CanadaApril 22, 2025 | markets.businessinsider.comThis Pharma Stock Is Gaining Major Steam Ahead Of Opening BellApril 2, 2025 | msn.comSunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer DrugApril 2, 2025 | benzinga.comSunshine Biopharma Announces Positive Results of mRNA Therapy for CancerApril 2, 2025 | finance.yahoo.comSunshine Biopharma signs agreement for rights to market two generic antibioticsMarch 24, 2025 | msn.comSunshine Biopharma Inc.: Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million MarketMarch 10, 2025 | finanznachrichten.deSunshine Biopharma’s Nora Pharma acquires gastrointestinal drug rightsMarch 10, 2025 | markets.businessinsider.comSunshine Biopharma reports Q3 revenue $8.4M vs. $5.96M last yearNovember 7, 2024 | markets.businessinsider.comSunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in SeptemberOctober 12, 2024 | marketbeat.comSunshine Biopharma (NASDAQ:SBFM) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comSunshine Biopharma (NASDAQ:SBFM) Shares Down 9.6% August 17, 2024 | marketbeat.comSBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024August 16, 2024 | investorplace.com3 Penny Stocks Ready to Explode Into Dollar Signs by 2028June 20, 2024 | investorplace.comSunshine Biopharma, Inc.: Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%May 21, 2024 | finanznachrichten.deSunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%May 21, 2024 | finance.yahoo.comSBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024May 20, 2024 | msn.com3 Meme Stocks to Sell That Even Roaring Kitty Can't SaveMay 16, 2024 | investorplace.comSBFM, BPTH and INDO among pre-market losersApril 22, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.56%April 19, 2024 | msn.comSunshine Biopharma, Inc.: Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of NeulastaApril 19, 2024 | finanznachrichten.deSunshine Biopharma (Nasdaq:SBFM) HeadlineTrading was temporarily halted for "SBFM" at 09:04 AM with a stated reason of "LULD pause."...April 17, 2024 | marketbeat.comSunshine Biopharma (Nasdaq:SBFM) HeadlineTrading was temporarily halted for "SBFM" at 07:04 PM with a stated reason of "News pending."...April 17, 2024 | marketbeat.comSunshine Biopharma, Inc.: Sunshine Biopharma Announces Reverse Stock SplitApril 12, 2024 | finanznachrichten.deSBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q4 2023April 8, 2024 | investorplace.comSBFM Sunshine Biopharma, Inc.April 4, 2024 | seekingalpha.comSunshine Biopharma IncorporatedMarch 6, 2024 | cnn.comWhy Is Sunshine Biopharma (SBFM) Stock Down 17% Today?March 4, 2024 | investorplace.comSunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public OfferingFebruary 15, 2024 | finance.yahoo.comAnalysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)January 23, 2024 | finance.yahoo.comSunshine Biopharma Stock (NASDAQ:SBFM) Dividends: History, Yield and DatesNovember 28, 2023 | benzinga.comSunshine Biopharma, Inc.: Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid ComplianceSeptember 21, 2023 | finanznachrichten.deSunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid ComplianceSeptember 21, 2023 | finance.yahoo.comWhat Are Sunshine Laws? Definition, Purpose, ExamplesSeptember 14, 2023 | investopedia.comIt's Down 26% But Sunshine Biopharma, Inc. (NASDAQ:SBFM) Could Be Riskier Than It LooksSeptember 12, 2023 | finance.yahoo.comWhen Will Sunshine Biopharma, Inc. (NASDAQ:SBFM) Breakeven?August 16, 2023 | finance.yahoo.comSunshine Biopharma Inc.: Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%August 11, 2023 | finanznachrichten.deSunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%August 11, 2023 | finance.yahoo.comAegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc.May 16, 2023 | finanznachrichten.deSunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketMay 16, 2023 | finance.yahoo.comAegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)May 16, 2023 | finance.yahoo.comSunshine Biopharma to sell 5.95M units at $0.84 in private placementMay 12, 2023 | msn.comSunshine Biopharma Shares Slide 22% Premarket on Private Placement >SBFMMay 12, 2023 | marketwatch.comSBFM Stock Alert: Why Sunshine Biopharma Is Down 28% TodayMay 12, 2023 | investorplace.comSunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketMay 12, 2023 | finance.yahoo.com Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address SBFM Media Mentions By Week SBFM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBFM News Sentiment▼-0.630.63▲Average Medical News Sentiment SBFM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBFM Articles This Week▼10▲SBFM Articles Average Week Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRA News Today NNVC News Today FBLG News Today TPST News Today ALXO News Today QTTB News Today CVKD News Today TENX News Today CARA News Today BCAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SBFM) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredWhy Elon put $51 million into thisEvery major AI breakthrough comes with a catch: It burns through power like jet fuel. Now Google, Microsof...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
